Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions

Am J Respir Crit Care Med. 2023 Jan 1;207(1):102-105. doi: 10.1164/rccm.202205-0910LE.

Authors

Yet H Khor^{1

2

3

4}, Malik Farooqi⁵, Nathan Hambly⁵, Martin Kolb⁵, Christopher J Ryerson^{6

7}; Austin ILD Registry and CARE-PF Investigators

Collaborators

Austin ILD Registry and CARE-PF Investigators:
Deborah Assayag, Gerard Cox, Charlene D Fell, Jolene H Fisher, Andrea S Gershon, Nicole Goh, Andrew J Halayko, Kerri A Johannson, Nasreen Khalil, Stacey Lok, Helene Manganas, Veronica Marcoux, Julie Morisset, Mohsen Sadatsafavi, Shane Shapera, Teresa To, Pearce G Wilcox, Alyson W Wong

Affiliations

¹ Monash University Melbourne, Victoria, Australia.
² Austin Health Heidelberg, Victoria, Australia.
³ Institute for Breathing and Sleep Heidelberg, Victoria, Australia.
⁴ University of Melbourne Melbourne, Victoria, Australia.
⁵ McMaster University Hamilton, Ontario, Canada.
⁶ University of British Columbia Vancouver, British Columbia, Canada.
⁷ St. Paul's Hospital Vancouver, British Columbia, Canada.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis*